On this page
What each program costs in Minnesota
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the Minnesota Advantage Health Plan (SEGIP) cover GLP-1s for weight loss?
Minnesota's Advantage Health Plan, in its 2026 Summary of Benefits, excludes weight-loss drugs unless they are medically necessary, appropriate treatment and part of a Plan-approved program.
Minnesota Management and Budget (SEGIP)
The 2026 Summary of Benefits, current as of January 1, 2026, lists weight-loss drugs among its exclusions unless three conditions are met.
“charges for weight loss, drugs, and programs, including program fees or dues, nutritional supplements, food, appetite suppressants, vitamins, and exercise therapy unless Medically Necessary, appropriate Treatment, and a Plan-approved program;”
https://mn.gov/mmb-stat/segip/doc/SoB_current_AHP.pdf · read Oct 29, 2026
Minnesota Management and Budget (SEGIP)
Its weight management section uses the same test for weight-loss programs.
“The Advantage Plan may cover a weight loss program if it is Medically Necessary, appropriate Treatment and Plan-approved.”
https://mn.gov/mmb-stat/segip/doc/SoB_current_AHP.pdf · read Oct 29, 2026
Does Minnesota Medicaid (Medical Assistance) cover GLP-1s for weight loss?
Covered, with conditions
Minnesota Medicaid lists Wegovy and Zepbound as covered anti-obesity drugs with prior authorization, including BMI and diet and activity requirements. Read from state documents Nov 6, 2026.
What Minnesota Medicaid (Medical Assistance)'s documents say about each drug for weight loss. Read Nov 6, 2026. Minnesota Department of Human Services.
WegovyYes
Prior authorization. Adults: BMI 30 or higher, or BMI 27 or higher with a weight-related condition. Ages 12 to 17: BMI 30 or higher and body weight above 60 kg. Diet and activity documentation; at least 5% weight loss to renew.
“Foundayo liraglutide (generic of Saxenda) Saxenda Wegovy Xenical Zepbound”
Minnesota Department of Human Services · No effective date on the document · read Nov 6, 2026
“Greater than or equal to 30 kg/m2 with no risk factors (for patient at least 18 years of age)”
Minnesota Department of Human Services · No effective date on the document · read Nov 6, 2026
“WEIGHT MANAGEMENT AGENTS section updated 12-1-2024”
Minnesota Department of Human Services · Effective May 7, 2026 · read Nov 6, 2026
ZepboundYes
Prior authorization. Adults: BMI 30 or higher, or BMI 27 or higher with a weight-related condition. Ages 12 to 17: BMI 30 or higher and body weight above 60 kg. Diet and activity documentation; at least 5% weight loss to renew.
“Foundayo liraglutide (generic of Saxenda) Saxenda Wegovy Xenical Zepbound”
Minnesota Department of Human Services · No effective date on the document · read Nov 6, 2026
“Greater than or equal to 30 kg/m2 with no risk factors (for patient at least 18 years of age)”
Minnesota Department of Human Services · No effective date on the document · read Nov 6, 2026
“WEIGHT MANAGEMENT AGENTS section updated 12-1-2024”
Minnesota Department of Human Services · Effective May 7, 2026 · read Nov 6, 2026
OzempicNot confirmed
The May 2026 Uniform PDL lists Ozempic under hypoglycemics, which does not answer weight loss. The anti-obesity list does not name it, and absence is not a no. No Ozempic-specific criteria could be read; other mn.gov criteria pages returned a bot check.
MounjaroNot confirmed
The May 2026 Uniform PDL lists Mounjaro as nonpreferred under hypoglycemics, which does not answer weight loss. The anti-obesity list does not name it, and absence is not a no. No Mounjaro-specific criteria could be read; other mn.gov criteria pages returned a bot check.
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Minnesota Department of Human Services documents. KFF's January 2026 map listed this program as covered; the documents we read agree.
Weight loss
Covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
124,503 prescriptions
Ozempic and Mounjaro, 2025
91,255 prescriptions
Neighbours covering weight loss
1 of 4
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Minnesota Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Minnesota Medicaid as "covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Minnesota Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Minnesota Medicaid pay for?
230,594 GLP-1 prescriptions in 2025, 12th of the 50 states and DC, with $255.3 million reimbursed before rebates. Counting the share other payers covered, $255.7 million.
Prescriptions, 2025
230,594
12th of 51
Medicaid paid
$255.3M
11th of 51, before rebates
Per prescription
$1,107
$1,051 nationally
Weight-loss brands
54%
9th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Minnesota is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 54% of Minnesota Medicaid's GLP-1 prescriptions in 2025 (124,503). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Wegovy was Minnesota Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Wegovyapproved for weight management | 90,988 | 39% | $118.7 million | $1,305 |
| Ozempic | 73,428 | 32% | $71.5 million | $973 |
| Zepboundapproved for weight management | 31,424 | 14% | $32.6 million | $1,039 |
| Mounjaro | 17,827 | 7.7% | $18.4 million | $1,032 |
| Liraglutide (generic) | 4,414 | 1.9% | $2.2 million | $493 |
| Trulicity | 4,299 | 1.9% | $4.6 million | $1,074 |
| Victoza | 2,612 | 1.1% | $1.7 million | $637 |
| Saxendaapproved for weight management | 2,091 | 0.9% | $2.4 million | $1,162 |
| Bydureon | 2,031 | 0.9% | $1.6 million | $801 |
| Rybelsus | 1,480 | 0.6% | $1.6 million | $1,084 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Minnesota?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 1 in Minnesota. The register does not say which, if any, supplies a program on this page.
- IntegraDose Compounding Services, LLC, Shoreview. Registered since Feb 13, 2026; last FDA inspection Aug 12, 2026.
On Medicare in Minnesota?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Minnesota and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 4 states next to Minnesota covers GLP-1s for weight loss through Medicaid: Wisconsin. None has a lower cash floor than Minnesota's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Minnesota | Covered | 19 | $39/mo |
| Iowa | Not covered | 19 | $39/moWellmedr |
| North Dakota | Not covered | 17 | $39/moWellmedr |
| South Dakota | Not covered | 19 | $39/moWellmedr |
| Wisconsin | Zepbound only | 19 | $39/moWellmedr |






















